drugset / Trial / NCT03167645

SUbstition of PERioperative Albumin Deficiency Disorders

NCT03167645

Phase 4 Completed 600 enrolled Technical University of Munich
RandomizedParallel-groupSingle-blindTreatment

Summary

Aim of this study is to reduce postoperative complications (assessed by POMS-Score and graded by Clavien-Dindo-Score) by substitution of perioperative hypoalbuminaemia in high-risk patients or patients undergoing high risk surgery.

Timeline

Start
2017-06-19
Primary completion
2019-12-21
Completion
2021-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic

Indications

No indication recorded.